CCL19 and breast cancer: And then, we embarked from the differentially expressed genes (DEGs) obtained by comparison between immune component and stromal component in BC samples and clarified that C-C motif chemokine 19 (CCL19) functioned as a potential prognostic biomarker and a modulator of TIME in BC through communicating with various TICs in TIME.